Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Schmidt Helena |

Präsentationen bei wissenschaftlichen Veranstaltungen

Schmidt, H Vom Leiden zum Erkenntnis: Biochemie des Eisenmangels
Eisen.akademie 3; MÄRZ 16-17, 2018; Fuschl am See. 2018. [Oral Communication]
FullText

 

Debette, S; Saba, Y; Vojinovic, D; Jian, X; Adams, H; Chauhan, G; Sargurupremraj, M; Kaffashian, S; Ding, J; Bis, JC; Nyquist, P; Mather, K; Van Duijn, C; Launer, LJ; Ikram, MA; Schmidt, H; Longstreth, WT; Fornage, M; Seshadri, S; 19th Workshop of the International Stroke Genetics Consortium, April 28-29, 2016, Boston, Massachusetts, USA: 2016.001 MRI-defined cerebrovascular genomics-The CHARGE consortium.
Neurol Genet. 2017; 3(1 Suppl 1):S2-S11. [Oral Communication] [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Schmidt, H Grazer Studie zur Alternsforschung: Strategien für ein gesundes Altern
Alternsmedizin trifft Traumatologie; 15.-16. September 2017; Linz, Austria. 2017. [Oral Communication]
FullText

 

Schmidt Helena, Saba Yasaman, on behalf of the NeuroCharge working group Hypertension stratified GWAS on white matter lesion burden
CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) Consortium Investigator Meeting; 22-24.03.2017; New York, NY, USA. 2017. [Oral Communication]
FullText

 

Mosbacher, JA; Waser, M; Garn H; Deistler M; Seiler S; Dal-Bianco, P; Ransmayr, G; Sanin, G; Schmidt, H; Lechner, A; Caravias G; Santer P; Grossegger D; Benke T; Zeitlhofer J; Schmidt, R Task related decoupling of a left anterior-posterior network relates to faster cognitive decline in AD
29. JAHRESTAGUNG DER ÖSTERREICHISCHEN ALZHEIMER GESELLSCHAFT (ÖAG); OKT 14-45, 2016; Hall in Tirol. 2016. [Oral Communication]

 

Piyush, Gampwar; Yasaman, Saba; Bemelmans, Maria; Semmler-Bruckner, Johan; Schmidt, Helena A comparative evaluation of two DNA exome library preparation methods for ion torrentTM Proton. 
European Human Genetics Conference 2016; May 21-24, 2016; Barcelona, Spain. 2016. [Poster]

 

Mosbacher, JA; Waser, M; Garn, H; Deistler, M; Seiler, S; Dal-Bianco, P; Ransmayr, G; Sanin, G; Schmidt, H; Lechner, A; Caravis, G; Santer, P; Grossegger, D; Benke, T; Zeitlhofer, J; Schmidt, R Reactivity of EEG functional connectivity to eye opening as predictor for AD progression
28. Jahrestagung der Österreichischen Alzheimergesellschaft; Oct 23-24, 2015; Linz, Austria. 2015. [Oral Communication]

 

Seiler, S; Pirpamer, L; Hofer, E; Langkammer, C; Koini, M; Mosbacher, J; Lechner, A; Petrovic, K; Homayoon, N; Stögerer, E; Reinhart, B; Troger, J; Dal-Bianco, P; Ransmayr, G; Benke, T; Schmidt, H; Marksteiner, J; Uranüs, M; Bancher, C; Kapeller, P; Haider, B; Leblhuber, F; Ropele, S; Schmidt, R; Microstructural brain tissue changes of the hippocampus relate to cognitive performance in Alzheimer’s disease –Results of the Prospective Dementia Registry in Austria (PRODEM)
Jahrestagung der Österreichischen Alzheimer Gesellschaft; OCT 23-24, 2015; Linz, AUSTRIA. 2015. [Oral Communication]

 

Schmidt, H Circulating miRNAs as possible biomarkers for cognitive decline in physiological brain aging and Alzheimer dementia
BI-IMBA-IMP meeting on microRNAs in human disease; 15-17 January 2014; Gumpoldskirchen, Austria. 2014. [Oral Communication]

 

Schmidt H Genetics of white matter lesions stratified on hypertension:results of the NeuroCHARGE working group
Meeting of the International Stroke Genomic Consortium; 6-7.11.2014; Paris, France. 2014. [Oral Communication]

 

Seiler, S; Bancher, C; Benke, T; Dal-Bianco, P; Kapeller, P; Lampl, C; Leblhuber, F; Marksteiner, J; Ransmayr, G; Schmidt, H; Uranüs, M; Ghadery, C; Grazer, A; Haider, B; Hofer, E; Homayoon, N; Lechner, A; Lehner, R; Lehrner, J; Loitfelder, M; Moser, D; Petrovic, K; Reinhart, B; Ropele, S; Sanin, G; Santer, P; Schmidt, R; Microstructural brain tissue damage in the hippocampus of AD patients: Magnetization Transfer Imaging results from the prospective dementia registry in Austria (PRODEM).
11. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 26-29, 2014; Salzburg, Austria. 2014. [Poster]

 

Töglhofer, AM; Hofer, E; Petrovic, KE; Freudenberger, P; Fixa, A; Schmidt, R, Schmidt, H Heritability of Age Related Cognition.
Proceedings of the ESHG Conference 2014; ESHG Conference; MAY 31 - JUN 03, 2014; Milan, ITALY. 2014; -European Human Genetics Conference 2014; Mai 31 - Jun 03, 2014; Milan, ITALY. [Poster]

 

Homayoon, N; Hofer, E; Petrovic, K; Loitfelder, M; Schmidt, H; Schmidt, R Anticardiolipin antibodies, cognition, and brain magnetic resonance imaging
Journal of the Neurological Sciences. 2013; 333: 309-310.-World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Sen, A; Freudenberger, P; Töglhofer, AM; Schmidt, R; Schmidt, H Higher plasma concentrations of total carotenoids are associated with slower cognitive decline: Results from the Austrian Stroke Prevention Study.
Jahrestagung der Österreichischen Alzheimer-Gesellschaft.; OCT 24-26, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]
FullText

 

SEN, A; Freudenberger, P; Töglhofer, AM; Schmidt, R; Schmidt, H; Association of higher concentrations of plasma carotenoids with better cognitive performance: Results of the Austrian Stroke Prevention Study.
World Congress of Neurology; SEP 21-23, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]
FullText

 

Sen, A; Petrovic, K; Freudenberger, P; Schallert, M; Nagl, C; Seiler, S; Schmidt, R; Schmidt, H Association of Leukocyte telomere length and MRI correlates of Brain Aging: Results of Austrian Stroke Prevention Study.
European Human Genetics Conference; JUN 8-11, 2013; Paris, FRANCE. 2013. [Poster]
FullText

 

Schmidt H Diagnostische Entwicklungen_Genetik
10.Jahrestagung der Österreichischen Gesellschaft der Neurologie; 14-17.März 2012; Graz. 2012. [Oral Communication]
FullText

 

Seiler, S; Hofer, E; Bancher, C; Benke, T; Dal-Bianco, P; Grossmann, J; Iglseder, B; Kapeller, P; Ladurner, G; Lampl, C; Leblhuber, F; Marksteiner, J; Psota, G; Ransmayr, G; Schmidt, H; Uranüs, M; Weiss, E; Grazer, A; Homayoon, N; Lechner, A; Lehner, R; Lehrner, J; Loitfelder, M; Moser, D; Petrovic, K; Reinhart, B; Sanin, G; Santer, P; Schmidt, R; Driving and Alzheimer's disease: Results from the Prospective Registry on Dementia (PRODEM) Austria
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz. 2012. [Poster]

 

Stögerer, EM; Biffi, A; Schmidt, R; Schmidt, H; Seifert-Held, T; Rosand, J; International Stroke Genetics Consortium Variants at APOE influence risk of deep and lobar intracerebral hemorrhage
neurologisch Fachmagazin für Neurologie. 2012; Supplementum (1/2012):85-85.-10. Jahrestagung der Österreichischen Gesellschaft für Neurologie ; MAR 14-17, 2012; Graz, AUSTRIA. [Poster]

 

Biffi, A; Kissela, B; Ayres, AM; Sonni, A; Gilson, AJ; Schwab, K; Cortellini, L; Pires, CR; Hansen, BM; Rost, NS; Goldstein, JN; Viswanathan, A; Lindgren, A; Slowik, A; Schmidt, R; Tirschwell, DL; Selim, M; Brown, DL; Silliman, SL; Worrall, BB; Meschia, JF; Broderick, JP; Greenberg, SM; Woo, D; Rosand, J APOE Genotype Predicts Hematoma Volume and Expansion in Intracerebral Hemorrhage
STROKE. 2011; 42(3):E102-E102. [Oral Communication]
Web of Science

 

Gider, P; Schmidt, R; Cavalieri, M; Zweiker, R; Watzinger, N; Schmidt, H CARDIORESPIRATORY FITNESS AND AGE-RELATED BRAIN CHANGES: A COMMUNITY-BASED MRI AND EXERCISE ECG STUDY
Proceedings of the „10th International Conference on AD/PD 2011“2011; -AD/PD 2011; 9-13, 2011; Barcelona, SPAIN. [Oral Communication]

 

Seiler, S; Benke, T; Ransmayr, G; Dal-Bianco, P; Schmidt, H; Grazer, A; Homayoon, N; Lechner, A; Lehner, R; Lehrner, J; Loitfelder, M; Moser, D; Petrovic, K; Sanin, G; Santer, P; Schmidt, R; Neuropsychiatric symptoms and caregiver burden in Alzheimer's disease.
Jahrestagung der Österreichischen Alzheimer Gesellschaft; SEP 16-17, 2011; Horn, AUSTRIA. 2011. [Poster]

 

Sen, A, Cavalieri M, Petrovic K, Enzinger C, Schmidt R, Schmidt H Association of leukocyte telomere length and MRI correlates of brain aging: Results of the Austrian Stroke Prevention Study (ASPS).
24th annual meeting of the Austrian Alzheimer Association; SEPT. 16-17, 2011; Horn, AUSTRIA. 2011. [Poster]
FullText

 

Debette, S; Bis, J; Fornage, M; Schmidt, H; Ikram, MA; Sigurdsson, S; Heiss, G; Struchalin, M; Smith, AV; van der Lugt, A; DeCarli, C; Lumley, T; Knopman, DS; Enzinger, C; Eiriksdottir, G; Koudstaal, PJ; DeStefano, AL; Psaty, BM; Dufouil, C; Catellier, DJ; Fazekas, F; Aspelund, T; Aulchenko, YS; Beiser, A; Rotter, JI; Tzourio, C; Shibata, DK; Tscherner, M; Harris, TB; Rivadeneira, F; Atwood, LD; Rice, K; Gottesman, RF; van Buchem, MA; Uitterlinden, AG; Kelly-Hayes, M; Cushman, M; Zhu, YC; Boerwinkle, E; Gudnason, V; Hofman, A; Romero, JR; Lopez, O; van Duijn, CM; Au, R; Heckbert, SR; Wolf, PA; Mosley, TH; Seshadri, S; Breteler, MMB; Schmidt, R; Laurier, LJ; Longstreth, WT Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis from the CHARGE Consortium
NEUROLOGY. 2010; 74(9):A222-A222.-62nd Annual Meeting of the American Academy of Neurology (AAN); APR 10-17, 2010; Toronto, CANADA. [Poster]
Web of Science

 

Homayoon, N; Cavalieri, M; Petrovic, K; Stögerer, E; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, H; Schmidt, R; Magnetisations Transfer Imaging und Kognitive Dysfunktion
8. Jahrestagung der österreichischen Gesellschaft für Neurologie ; Feb 24-27, 2010; Linz, Austria . 2010. [Oral Communication]

 

Schmidt, H Epigenetik und Alzheimer
23. Jahrestagung der Österreichische Alzheimer Gesselschaft; 3-4.September, 2010; Villach, Austria. 2010. [Oral Communication]
FullText

 

Schmidt, H Genetische Risikofaktoren bei Gehirnalterung
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark Sitzung des Forschungsfelds Neurowissenschaften ; 10. Juni 2010; Graz, austria. 2010. [Oral Communication]

 

Schmied, M; Zehetmayer, S; Bajer-Kornek, B; Hotzy, C; Zebenholzer, K; Leutmezer, F; Kristoferitsch, W; Reindl, M; Khalil, M; Fuchs, S; Schmidt, H; Fazekas, F; Berger, T; Vass, K; Zimprich; A Assoziationsanalyse von Kandidatenloci für Multiple Sklerose
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Homayoon, N; Cavalieri, M; Petrovic, K; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, H; Schmidt, R; Magnetisation Transfer Imaging und kognitive Dysfunktion
22. Jahrestagung der österreichischen Alzheimer Gesellschaft; Nov 27-28, 2009; Graz, Austria. 2009. [Oral Communication]

 

Schmidt H Erforschung neurogenetischer Erkrankungen
7. Arbeitstagung der Plattform “Niedergelassene NeurologInnen”der ÖGNin Zusammenarbeit mit der Fachgruppe Neurologie; 4-5 Dezember; Salzburg, Austria. 2009. [Oral Communication]

 

Schmidt H Aß and the role of Preseniline mutations
6th International Winter Conference on Alzheimer's Disease; 6-9 December 2009; Zürs, Austria. 2009. [Oral Communication]

 

Schmidt H Erforschung neurogenetischer Erkrankungen
ÖGN Fortbildungsakademie Neurogenetik, 7. Jahrestagung der Österreichischen Gesellschaft für Neurologie mit FORTBILDUNGSAKADEMIE und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation.; 25.-28. März 2009; Congress Center Villach. 2009. [Oral Communication]

 

Schmidt H Presenilin oder beta-amyloid? - zwei konkurierende Hypothesen
22. Jahrestagung der Österreichischen Alzheimer Gesellschaft; 27.-28. November 2009; Graz, Austria. 2009. [Oral Communication]
FullText

 

Schmidt H “Beyond the role of Aâ and Presenilin mutations in AD: novel findings of genetic studies”
6th International Winter Conference on Alzheimer's Disease; 5- 8t December 2009; Zürs, Austria. 2009. [Oral Communication]

 

Schmidt, H; Tscherner, M; Schmidt, R The role of common and rare variants in NOTCH3 Gene in age associated cerebral small vessel disease.
http://www.ashg.org/2009meeting/abstracts/fulltext/2009; -59th Annual Meeting of The American Society of Human Genetics; 20-24 October 2009; Honolulu, Hawaii; USA. [Poster]
FullText

 

Schmidt, R; Schmidt H Das menschliche Genom, Genetische Variabilität, Regelung lt Gentechnikgesetz
Facharztausbildungsseminar der ÖGN; NOV 5-7, 2009; Graz, Austria. 2009. [Oral Communication]

 

Stögerer, EM; Perovic, K; Cavalieri, M; Schmidt, H; Homayoon, N; Reinhart, B; Pluta-Fürst, A; Schmidt, R Die normale Varianz von Gedächtnis und Gedächtnisabbau im Alter: 6-Jahres-Ergebnisse der Austrian Stroke Prevention Study
neurologisch, Fachmagazin für Neurologie. 2009; Suppl. 1/2010: 62-63.-8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB 24-27, 2010; Linz, AUSTRIA . [Poster]

 

Stögerer,EM; Petrovic, K;Cavalieri, M;Schmidt, H;Homayoon, N; Reinhart,B; Pluta-Fürst, A; Schmidt, R Die normale Varianz von Gedächtnis und Gedächtnisabbau im Alter: 6 Jahres Ergebnisse der Austrian Stroke Prevention Study.
22. Jahrestagung der Österreichischen Alzheimer Gesellschaft; NOV 27-28, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Tscherner, M; Schmidt, H; Schmidt, R NOTCH3 Gene and Cerebral Small Vessel Disease
neurologisch2009; Sonderausgabe: 68-69.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Tscherner, M; Schmidt, H; Schmidt, R NOTCH3 Gene and Cerebral Small Vessel Disease.
Abstractbook of the European Conference of Human Genetics 20092009; -European Conference of Human Genetics 2009; May 23 – 26, 2009; Austria Center Vienna, Austria. [Poster]

 

Wang J,Tscherner M, Schmidt R, Fazekas F , Schmidt H Genetic variations in nitric oxide synthase genes NOS1, NOS2A and NOS3 and cerebral small vessel disease
Abstractbook of the European Conference of Human Genetics 2009; -European Conference of Human Genetics ; May 23 – 26, 2009; Austria Center Vienna, Austria. [Poster]

 

Zeginigg, M; Düttmann, W; Schmidt, R; Schmidt, H The role of common and rare variants in NOTCH3 gene in age associated cerebral small vessel disease.
7. Jahrestagung der Österreichischen Gesellschaft für Neurologie; 25.-28. März 2009 ; Villach. 2009. [Poster]

 

Friedl, G; Rehak I, Schmidt H, Kostner G, Stadelmeyer E; Schulz E, Aigner R, Windhager R RESISTANCE OF UNDIFFERENTIATED MESENCHYMAL STEM CELLS TO THE OSTEOGENIC MECHANORESPONSE IN OBESE PATIENTS
Proceedings of the 9th EFORT Congress, Nice, France2008; -9th Congress of European Federation of National Associations of Orthopaedics and Traumatology (EFORT); MAY 29 - JUN 1, 2008; Nice, FRANCE. [Oral Communication]

 

Friedl, G; Rehak, I, SChmidt, H; Schauenstein, K; Stadelmeyer, E, Schulz, E;Aigner, R; Windhager, R Resistance to osteogenic mechanoresponse of undifferentiated hMSCs: upstream imprinting related to donor's fat metabolism.
Abstract Band2008; -54th Annual Meeting of the Orthopaedic Research Society (ORS); March 2-5, 2008; San Francisco, CA, USA. [Poster]

 

Schmidt, H New Perspectives of Genetics of Alzheimer’ disease
5th International Winter Conference on Alzheimer's Disease; 6-9 December 2008; Zürs, Austria. 2008. [Oral Communication]
FullText

 

Schmidt, H Genetics: Present Status The lesson of genetic studies in Alzheimer's: What did we learn so far?
21. Jahrestagung der Österreichischen Alzheimer Gesellschaft; 19.-20. September 2008; Wien Austria. 2008. [Oral Communication]
FullText

 

Schmidt H The genetics of Alzheimer Disease- What did we learn so far?
21. Jahrestagung der Österreichische Alzheimer Gesellschaft; 19-20.September; Vienna, Austria. 2008. [Oral Communication]

 

Schmidt H Presenilin oder Amyloid - zwei konkurrierende Hypothesen ?
Abstractbook of 5th International Winter Conference on Alzheimer's Disease2008; -5th International Winter Conference on Alzheimer's Disease; 6-9 December 2008; Zürs, Austria. [Oral Communication]

 

Friedl, G; Rehak, I; Schmidt, H; Kostner, G; Schauenstein, K; Rehak, P; Windhager, R THE ROLE OF C-FOS IN EARLY OSTEOCHONDRAL RESPONSE OF HUMAN MESENCHYMAL STEM CELLS TO MECHANICAL STRAIN.
53rd Annual Meeting of the Orthopaedic Research Society2007; -53rd Annual Meeting of the Orthopaedic Research Society; February 11-14, 2007; San Diego, CA, USA. [Oral Communication]

 

Friedl, G; Rehak, I; Schmidt, H; Kostner, G; Schauenstein, K; Windhager, R FUNCTIONAL CHARACTERIZATION OF HUMAN MESENCHYMAL STEM CELLS REPRESENTS DONOR-SPECIFIC OSTEOGENIC RESPONSE TO PHYSICAL STIMULI IN VITRO.
Abstract Band2007; -3rd Annual Meeting of the Orthopaedic Research Society; Feb 11-14, 2007; San Diego, CA, USA. [Oral Communication]

 

Pichler M, Schmidt R, Mark T, Becsagh P, Fazekas F, Schmidt H C-reactive protein 3´UTR +1444C>T polymorphism in patients with carotid atherosclerosis
Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Alzheimer, Neurologie und Psychiatrie; APR 25-28, 2007; Salzburg. 2007. [Oral Communication]

 

Schmidt H Genetics of Alzheimer`s Disease
Abstractbook of the 4th International Conference on Alzheimer Disease2007; -4th International Conference on Alzheimer Disease; 7-11.December, 2007; Zürs, Austria. [Oral Communication]

 

Schmidt,H; Petrovic,K;Ropele, S; Fazekas,F; Schmidt R Differential risk factor profile for ischemic white matter damage in elderly hyper-and normotensives: Results of the Austrian Stroke Prevention Study
Abstractbook of VAS-COG 20072007; -VAS-COG 2007; 11-17.July, 2007; San Antonio, USA. [Poster]
FullText

 

Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H The +1444C>T polymorphism in the 3´untranslated region of CRP gene influences baseline C-reactive protein serum level
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL.44(NO.9):205-206.-1st Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OKT 4-7, 2006; Salzburg, AUSTRIA. [Poster]

 

Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H The +1444C>T polymorphism in the 3´untranslated region of CRP gene influences baseline C-reactive protein serum level
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL.44(NO.9):139-140.-Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin; OKT 1-4, 2006; Mannheim, GERMANY. [Oral Communication]

 

Pichler, M; Schmidt, R; Becsagh, P; Fazekas, F; Schmidt, H Baseline C-reactive protein serum level and the influence of CRP gene polymorphisms
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. CLINICAL CHEMISTRY AND LABORATORY MEDICINE.2006; VOL.44(NO.9):205-206.-1st Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OKT 4-7, 2006; Salzburg, AUSTRIA. [Poster]

 

Schmidt H Genetic determinants of cerebral small vessel disease
Doctorate Day of the Erasmus University Rotterdam; 19.Juli 2006; Rotterdam, Niederlande. 2006. [Keynote lecture]

 

Schmidt H Das menschliche Genom
Fach Arzt Ausbildungseminar; 3-4.November, 2006; Graz, Austria. 2006. [Oral Communication]

 

Schmidt H Monogenetische und multifaktorielle Erkrankungen
Facharzt Ausbildungsseminar; 3-4.Nov, 2006; Graz, Austria. 2006. [Oral Communication]

 

Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R. Baseline variables associated with a higher rate of brain atrophy in normal ageing – longitudinal brain volume change over 6 years in the Austrian Stroke Prevention Study.
2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders; Florence, Italy; June 2005. 2005. [Poster]

 

Enzinger C, Ropele S, Schmidt H, Fazekas F, Schmidt R Progression of cerebral white matter lesions – clinical and radiological considerations
J Neurol Sci. 2007 Jun 15. 2005; -4th International Congress on Vascular Dementia; 21-23 October; Porto, Portugal. [Oral Communication]

 

Schmidt H Genetics of Alzheimer`s Disease
18.Jahrestagung der Österreichische Alzheimer Gesellschaft; 18-19.Mai 2005; Horn, Österreich. 2005. [Oral Communication]

 

Schmidt H Introduction to Genetics: Human Genome and Modes of Inheritance –
2nd Congress of The International Society for Vascular Behavioural and Cognitive Disorders Teaching Session VIII: What is in the genes? Genetics of stroke and VCI; 8-12.June; Florence, Italy. 2005. [Oral Communication]
FullText

 

Petrovic, KE; Schmidt, R; Fazekas, F; Schmidt, H MRI predictors of cognitive decline in the normal elderly: 6-year results of the Austrian stroke prevention study
INT J PSYCHOL. 2004; 39: 190-190.
Web of Science

 

Enzinger C, Ropele S, Fazekas F, Schmidt H, Schmidt R Rapide Progression von konfluierenden white matter lesions: 6-Jahresergebnisse der Austrian Stroke Prevention Study.
6. Jahrestagung der österreichischen Gesellschaft für Schlaganfall-Forschung (ÖGSF); Innsbruck. 2003. [Oral Communication]

 

Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews P, Fazekas F. Tissue damage in multiple sclerosis and the APOE genotype – MRI analysis of brain volume changes and the evolution of “black holes” during two years of follow-up.
Multiple Sclerosis. 2003; 9(S1):S13--19th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; September 17¿20; Milan, Italy. [Poster]

 

Enzinger C, Ropele S, Strasser–Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung H.-P, Fazekas F Protonenspektroskopische Verlaufsuntersuchung zeigt stärkere Reduktion von N-Acetylaspartat bei Multiple Sklerose Betroffenen mit dem Apolipoprotein E e4 Allel.
1. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Innsbruck. 2003. [Oral Communication]

 

Petrovic K, Enzinger C, Ropele S, Schmidt H, Fazekas F, Schmidt R Progression von white matter lesions und Kognition: 6-Jahres Ergebnisse der Austrian Stroke Prevention Study.
6. Jahrestagung der österreichischen Gesellschaft für Schlaganfall-Forschung (ÖGSF); Innsbruck. 2003. [Oral Communication]

 

Poltrum B, Enzinger C, Strasser–Fuchs S, Ropele S, Kapeller P, Schmidt H, Schmidt R, Fazekas F tärkere Zunahme an T1-hypointensen Läsionen („black holes“) als Hinweis für höhere Gewebsdestruktion in Gehirnen Multiple Sklerose Betroffener mit dem APOEe4 Allel
1. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Innsbruck. 2003. [Poster]

 

Schmidt H, Schmidt R, Fazekas F, Kleinert G, Kapeller P, Enzinger C, Kleinert R Apolipoprotein E und Kleingefäßerkrankung des Gehirns: Eine immunhistochemische und in-situ Hybridisierung Studie.
6. Jahrestagung der österreichischen Gesellschaft für Schlaganfall-Forschung (ÖGSF); Innsbruck. 2003. [Oral Communication]

 

Schmidt H, Thaci A, Enzinger C, Ropele S, Fazekas F, Kostner GM, Pölzl I, Schmidt R ApoE Promotor Polymorphismus und zerebrale Mikroangiopathie. Ergebnisse der Austrian Stroke Prevention Study.
6. Jahrestagung der österreichischen Gesellschaft für Schlaganfall-Forschung (ÖGSF); Innsbruck. 2003. [Oral Communication]

 

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F Cerebral Small Vessel Disease on MRI: Benign or Malignant ?
The First International Conference of Brain Aging; Oct; Bucharest, Romania. 2003. [Oral Communication]

 

Schweighofer, N; Frank, S; Schmidt, R; Aulchenko, A; Schmidt, H Angiotensinogen haplotype related to cerebral small vessel disease increases promoter activity
CIRCULATION 2003 108: 348-348.
Web of Science

 

Schweighofer, N; Frank, S; Schmidt, R; Aulchenko, A; Schmidt, H, Angiotensinogen haplotype related to cerebral small vessel disease increases promoter activity
Abstractbook of the THE FIRST CONGRESS OF THE INTERNATIONAL SOCIETY FOR VASCULAR BEHAVIOURAL AND COGNITIVE DISORDERS (VAS-COG 2003)2003; -THE FIRST CONGRESS OF THE INTERNATIONAL SOCIETY FOR VASCULAR BEHAVIOURAL AND COGNITIVE DISORDERS (VAS-COG 2003) ; AUGUST 28-31, 2003 ; GÖTEBORG, SWEDEN. [Poster]
FullText

 

Enzinger C, Fazekas F, Ropele S, Kapeller P, Lechner A, Schmidt H, Schmidt R Vaskuläre Demenz und „Austrian Stroke Prevention Study“
2. Wiener Rathaustag anlässlich des „World Stroke Day“; Wien. 2002. [Oral Communication]

 

Enzinger C, Kapeller P, Strasser-Fuchs S, Ropele S, Schmidt H, Poltrum B, Schmidt R, Fazekas F. Protonenspektrokopische Verlaufsuntersuchung zeigt stärkere N-Acetlyaspartat Reduktion bei Multiple Sklerose Betroffenen mit dem APOE e4Allel
Gemeinsame Tagung der Österreichischen Gesellschaft für Neurologie (ÖGN) und der Österreichischen Gesellschaft für Psychiatrie (ÖGP); Gmunden. 2002. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Poltrum B, Schmidt H, Schmidt R, Fazekas F Serielle Kernspintomographische Veränderungen bei Multipler Sklerose in Abhängigkeit vom Apolipoprotein E Genotyp.
Gemeinsame Tagung der Österreichischen Gesellschaft für Neurologie (ÖGN) und der Österreichischen Gesellschaft für Psychiatrie (ÖGP); Gmunden. 2002. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Poltrum B, Schmidt H, Schmidt R, Fazekas F. Higher proportion of black holes in MS patients with APOE e4 allele.
Journal of Neurology. 2002; 249(S1):174--Twelfth Meeting of the European Neurological Society (ENS); June 22¿26; Berlin, Germany. [Poster]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Seifert T, Poltrum B, Schmidt H, Schmidt R, Fazekas F Evidence of more extensive tissue damage in MS patients with APOE-e4: two-year MRI follow-up shows higher proportion of lesions evolving to “black holes”.
European Journal of Neurology. 2002; 9(S2):29--6. Sixth European Federation Neurologic Society (EFNS) Congress; 26 - 30 October ; Vienna. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Seifert T, Poltrum B, Schmidt H, Schmidt R, Fazekas. F MRI evidence of more extensive tissue damage in MS patients with the e4 allele of Apolipoprotein E: higher proportion of lesions evolving to “black holes” during two-year follow-up.
Multiple Sclerosis 2002;(S1):3.2002; -7th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and 18th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; September 18-21; Baltimore, Maryland, USA.. [Oral Communication]

 

Petrovic K, Saurugg R, Schmidt H, Fazekas F, Kapeller P, Gratzl T, Lechner A, Enzinger C, Schmidt R Risikofaktoren und kognitiver Abbau: Longitudinale Ergebnisse der Austrian Stroke Prevention Study.
5. Jahrestagung der österreichischen Gesellschaft für Schlaganfall-Forschung (ÖGSF); Salzburg. 2002. [Oral Communication]

 

Enzinger C, Ropele S, Strasser-Fuchs S, Schmidt H, Kapeller P, Poltrum B, Schmidt R, Hartung H.P, Fazekas F. Apolipoprotein E e4 is associated with lower concentrations of N-acetylaspartate (NAA): a longitudinal 1H-MRS study in MS.
Multiple Sclerosis 2001;7(S1):288.2001; -ECTRIMS; Sept; Dublin. [Poster]

 

Schmidt, H; Fazekas, F; Schmidt, R Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology
Abstractbook2001; -International Symposium on ageing and dementia, Graz; 28-30.SEPT 2001; Graz, Austria. [Oral Communication]

 

Petrovic, KE; Lechner, A; Reinhart, B; Roob, G; Schmidt, H; Schmidt, R Predictors of cognitive decline in the Austrian stroke prevention study
INT J PSYCHOL 2000 35: 391-391.
Web of Science

 

Fazekas F, Enzinger C, Strasser-Fuchs S, Schmidt H, Lechner A, Ropele S, Flooh E, Schmidt R, Hartung HP. ApoE genotype of MS patients affects the severity of tissue destruction as seen on MRI.
Journal of Neurology 1999;246(S1), I/35. 1999; -Twelfth Meeting of the European Neurological Society; 22–26 June; Berlin, Germany. [Oral Communication]

 

Fazekas, F; Enzinger, C; Strasser-Fuchs, S; Schmidt, H; Lechner, A; Ropele, S; Flooh, E; Schmidt, R; Hartung, H-P ApoE genotype of MS patients affects the severity of tissue destruction as seen on MRI.
J Neurol((suppl 1) 1999; I/35 1999; I/35-I/35.-Annual Meeting of the European Neurological Society, ; 1999; Mailand, Italy,. [Oral Communication]

 

Kostner, GM; Schmidt, H; Schmidt, R The role of lipids, lipoproteins and oxidative stress in ischemic stroke and CVD.
Abstractbook1999; -East European Stroke Conference. ; March 18-20.1999; Budapest, Hungary. [Oral Communication]

 

Kostner, GM; Schmidt, H; Schmidt, R The role of lipids, lipoproteins and oxidative stress in ischemic stroke and CVD
East European Stroke Conference.Book of Abstracts. ;91999; -East European Stroke Conference.; 1999; Vienna, Austria. [Oral Communication]

 

Schmidt, H; Fazekas, F; Kostner, GM; Schmidt, R Genetic aspects of microangiopathy-related cerebral damage.
International Symposium on Aging and Dementia,; 1999; Graz, Austria . 1999. [Oral Communication]

 

Schmidt, H; Schmidt, R; Gradert, A; Fazekas, F; Franzens, K; Lechner, A; Roob, G; Schumacher, M; Kostner, GM Angiotensinogen (AGT) promoter haplotype is associated with silent ischemic brain damage (SIBD): Results of the Austrian stroke prevention study
CIRCULATION 1999 100: 181-181.
Web of Science

 

Strasser-Fuchs S, Schmidt H, Fazekas F, Enzinger C, Lechner A, Flooh E, Schmidt R, Hartung H-P ApoE genotype and clinical course of MS: a cross-sectional study.
Journal of Neurology 1999;246(S1),I/601999; -Twelfth Meeting of the European Neurological Society; 22–26 June; Berlin, Germany. [Poster]

 

Watzinger, N; Schumacher, M; Schmidt, R; Schmidt, H; Eber, B; Fruhwald, FM; Zweiker, R; Kostner, GM; Klein, WW Angiotensinogen M235T polymorphism in patients with risk of coronary artery disease
CIRCULATION 1999 100: 822-822.
Web of Science

 

Schmidt, H; Niederkorn, K; Horner, S; Fazekas, F; Schmidt, R Genetische Polymorphismen als Risikofaktoren für Karotissklerose in der Austrian Stroke Prevention Study.
1. Österreichische Wissenschaftliche Schlaganfall-Tagung.; 16-17.1.1998; Linz, Austria. 1998. [Oral Communication]

 

Schmidt, H; Schmidt, R; Fazekas, F; Schumacher, M; Kapeller, P; Watzinger, N; Hartung, HP; Kostner, GM The Met-Leu54 polymorphism is associated with progression of microangiopathy-related cerebral abnormalities (MARCA)on MRI: 3-year follow-up results of the Austrian Stroke Prevention Study
CIRCULATION. 1998; 98: 30-30.-American Heart Association Meeting;
Web of Science

 

Schmidt, R; Fazekas, F; Kapeller, P; Schmidt, H; Roob, G; Hartung, HP A 3-year follow-up study on MRI white-matter hyperintensities in normal persons: Rate, predictors, and neuropsychologic consequences of progression
NEUROLOGY 1998 50: A439-A440. [Oral Communication]
Web of Science

 

Schmidt, R; Schmidt, H; Niederkorn, K; Schumacher, M; Kostner, GM Paraoxonase polymorphism Met-Leu-54 is associated with Carotid arteriosclerosis.
J.Neurol 1998; 245:: 358-358.-Annual Meeting of the European Neurological Society; 1998; Nizza,, Frankreich. [Oral Communication]

 

Schumacher, M; Watzinger, N; Schmidt, R; Schmidt, H; Eber, B; Fruhwald, FM; Zweiker, R; Kostner, GM; Klein, W The paroxonase polymorphism Met-Leu54 in patients with disk for coronary heart disease
CIRCULATION 1998 98: 532-532.
Web of Science

 

Fazekas, F; Flooh, E; Kapeller, P; Kleinert, R; Offenbacher, H; Reinhart, B; Roob, G; Schmidt, H; Schmidt, R The spectrum of age-associated brain abnormalities, their measurements and pathohystological correlates.
Abstractbook.1997; -International Symposium on ageing and dementia; 17-19.Okt.1997; Graz, Austria. [Oral Communication]

 

Schallmoser, K; de Campo, A; Schmidt, H; Kostner, GM; Toplak, H Familiäre Hypercholesterinämie (LDL-Rezeptor-Mutation-Graz)-eine Familienanalyse.
Abstraktband.1997; -Jahrestagung der Österreichischen Atherosclerosegesellschaft,; 1997; Dürnstein, Austria. [Oral Communication]

 

Schmidt H Screening von genetischer Risikofaktoren für Atherosklerose.
4. Austrian Lipid Board Meeting; 17.10.1997; Graz.Austria. 1997. [Oral Communication]

 

Schmidt, H; Rohac, M; Waldhäusl, W; Semmler, J; Kostner, GM Clustering of the apoB-3500 defect and two different mutations in the LDL-receptor gene in a single person with familial hypercholesterolemia.
Abstract book. 1997; -International Workshop on Familial Hypercholesterolemia and the LDL-receptor. ; March, 20-23, 1997 ; Amsterdam, the Netherlands. [Oral Communication]

 

Schmidt, H; Schmidt, R; Fazekas, F; Schumacher, M; Kapeller, P; Kostner, GM ApolipoproteinE e4 Allele and Cerebral Aging. Results from the Austrian Stroke Prevention Study.
Book of abstracts1997; -16th Congress of the International Association of Gerontology,; 19-23. August, 1997; Adelaide, Australia. . [Oral Communication]

 

Schmidt, H; Schmidt, R; Fazekas, F; Schumacher, M; Kapeller, P; Kostner, GM ApolipoproteinE Polymorphism and Microangiopathy-Related Brain Damage. Results from the Austrian Stroke Prevention Study.
Abstractbook1997; -16th Congress of the International Association of Gerontology; 19-23. August, 1997; Adelaide, Australia.. [Oral Communication]

 

Schmidt, H; Schmidt, R; Niederkorn, K; Horner, S; Kostner, GM Beta-fibrinogen gene polymorphism (C>T-148) and carotid atherosclerosis. The Austrian Stroke Prevention Study.
Abstract book.1997; -7th Meeting of the European Neurological Society; 1997; Rhodos, Greece. [Oral Communication]

 

Schmidt, H; Schmidt, R; Niederkorn, K; Schumacher, M; Kostner, GM Paraoxonase polymorphism Met-Leu54 is associated with carotid atherosclerosis
CIRCULATION 1997 96: 189-189. [Oral Communication]
Web of Science

 

Schmidt, R; Fazekas, F; Kapeller, P; Reinhart, B; Schmidt, H The timely evolution of white matter abnormalities: Rate and predictors of progression (The Austrian Stroke Prevention Study).
Abstractbook. 1997; -International Symposium on ageing and dementia,; 17-19.Okt.1997; Graz, Austria. [Oral Communication]

 

Schmidt, R; Hayn, M; Reinhart, B; Roob, G; Esterbauer, H Antioxidants and Coognitive Functioning. Results of the Austrian Stroke Prevention Study
Abstract book.1997; -7th Meeting of the European Neurological Society; 1997; Rhodos, Greece. [Oral Communication]

 

Schmidt, R; Schmidt, H; Horner, S; Becsagh, P; Fazekas, F; Schumacher, M; Kostner, GM Beta-fibrinogen gene polymorphism, carotid atherosclerosis and microangiopathy-related cerebral damage; Results of the Austrian stroke prevention study
CIRCULATION 1997 96: 188-188. [Oral Communication]
Web of Science

 

Streicher, J; Valent, P; Schmidt, H; Sengolge, G; Banyai, S Stimulation of LDL receptor expression by LDL-immuno-apheresis in patients with heterozygous familial hypercholesterolemia
ATHEROSCLEROSIS 1997 134: 362-362. [Oral Communication]
Web of Science

 

Schmidt, H Gendefekte in Österreich: Aktuelle Situation.
Austrian Lipid Board -Meeting.; 26.2.1996,; Linz, Austria. 1996. [Oral Communication]

 

Schmidt, R; Fazekas, F; Hayn, M; Kapeller, P; Schmidt, H; Kostner, GM; Lechner, H; Esterbauer, H Prevalence and risk factors for silent ischemic brain damage on MRI: The Austrian stroke prevention study
NEUROLOGY 1996 46: 4011-4011.
Web of Science

 

Schmidt, R; Schmidt, H; Kapeller, P; Semmler, J; Fazekas, F; Niederkorn, K; Schumacher, M; Offenbacher, H; Kostner, GM Apolipoprotein E polymorphism and silent ischemic brain damage. Results from the Austrian stroke prevention study.
CIRCULATION 1996 94: 2279-2279. [Poster]
Web of Science

 

Schmidt, R; Schmidt, H; Kapeller, P; Semmler, J; Fazekas, F; Niederkorn, K; Schumacher, M; Offenbacher, H; Kostner, GM Apolipoprotein E polymorphism and Silent Ischemic Brain Damage. Results from the Austrian Stroke Prevention Study.
Abstraktband. 1996; - 13. Jahrestagung Österreichische Gesellschaft für Neuroimaging ; 15-16. November 1996 ; Graz. [Oral Communication]

 

Widhalm, K; Hyunn, C; Schmidt, H Eine neue Punktmutation (Frame-Shift bei Codon 437) als Ursache für eine schwere familiäre Hypercholesterinämie (FH).
Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; 1996; Mayrhofen, Austria. 1996. [Oral Communication]

 

Schmidt, H; Kostner, GM Screening of patients with familial hypercholesterolemia for mutations in the low density lipoprotein-receptor gene in the austrian population
Abstractbook.65th Meeting of the European Atherosclerosis Society, , 19951995; -65th Meeting of the European Atherosclerosis Society; 1995; Aarhus, Denmark. [Oral Communication]

 

Schmidt, H; Schmidt, R; Reinhart, B; Semmler, J; Fazekas, F; Kapeller, P; Kostner, GM ApolipoproteinE e4 allele in the normal elderly: neuropsychologic and brain MRI correlates.
XIIth International Symposium on Drugs Affecting Lipid Metabolism, Abstractbook 1995; 12 1995; -XIIth International Symposium on Drugs Affecting Lipid Metabolism, Abstractbook 1995; 12 ; 1995; Houston,Tx, USA. [Oral Communication]

 

Schmidt, R, Schmidt, H; Reinhart, B; Fazekas, F; Kapeller, P; Kostner, GM; Lechner, H ApolipoproteinE e4 allele in the normal elderly: neuropsychologic and brain MRI correlates.
Abstractbook1995; -Fourth International Symposium of Research Initiative EBEWE; 1995; Graz, Austria. [Oral Communication]

 

© Meduni Graz Impressum